Tag: Cancer: Thyroid

Standardized incidence ratios elevated for all nonkeratinocyte skin cancers, melanoma

No increased risk for thyroid cancer seen with use of GLP1 receptor agonist versus DPP4 inhibitor use, SGLT2 inhibitor use

Overall and one-, three-, and five-year PFS rates did not differ for microwave ablation and surgical resection

Estrogen gender-affirming hormone therapy may be a risk factor

56 percent increased rate of thyroid cancer diagnosis seen per doubling of linear perfluorooctanesulfonic acid intensity

No significant improvement in progression-free, overall survival seen with addition of lenalidomide to cediranib

Self-reported failure to have understanding of treatment linked to failure to meet treatment expectations

Highest risk for thyroid cancer seen among participants with both high genetic risk and unfavorable lifestyle

Patients undergoing immediate surgery experience greater anxiety than patients in active surveillance

Forty-six percent of patients who underwent thyroid-directed surgery had cancer; of these, 51 percent were asymptomatic